The Blog

Meaningful photos, videos, and stories.




Scientists have identified over 60 compounds that are unique to the Cannabis plant. We call them Phytocannabinoids. These compounds affect us because of their similarity to ones our body creates naturally. Every plant produces different amounts of each phytocannabinoid due to factors like genetics and environment.

While we have been living alongside the plant for thousands of years, the proliferation of Cannabis within the past 80 years has been carried out by those supplying a product for a recreational market. When deciding which plants to grow, and hence which genetic instructions to propagate, producers have favored strains that produce high levels of one particular phytocannabinoid, THC or Tetrahydracannabinol. THC is responsible for the psychoactive effects of Cannabis, or the euphoric "high". With no readily available product testing, this "high" was the only indication of "good" or "bad" product. As production decisions were driven by this mindset, parts of the gene pool that would result in high production levels of phytocannabinoids other than THC were lost.

Mendel's Seven Traits

Growing for Therapeutic Effect

Thanks to the developing political and cultural perceptions about Cannabis, as well as best practices for testing, cultivators have recently been able to breed and grow Cannabis with the intent of creating a therapeutic product comprised of more than just THC. This often involves multiple generations of production and intensive testing, tracking, and breeding.

As we progress in exploring potential benefits that the rest of the phytocannabinoids can provide, one in particular has gained prominence, CBD (Cannabidiol). This compound displays a host of pharmacological effects that are forcing important people to answer the question, "Where does Cannabis fit in with our health?". While we continue to change government policy that impedes the rigorous scientific studies needed to fully understand this important compound, there is no shortage of anecdotal feedback on the ability of CBD products to help patients dealing with seizures, cancer, rheumatoid arthritis and other autoimmune diseases, gastrointestinal issues, anxiety, and more.  It is our observation that a product with 1:1 ratio of THC to CBD can provide the most therapeutic benefit. Adjusting that ratio is a matter of noting your symptoms as well as your interactions Cannabis. If you would like to take the time to sit down with a consultant at The CPC in order to add structure to using CBD products in your treatment, head over to our "Become a Member" page.

The CPC Seattle CBD THC Cannabis Oil Capsules Indica Sativa